IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 213 filers reported holding IMMUNOMEDICS INC in Q4 2018. The put-call ratio across all filers is 1.36 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $16,000 | -11.1% | 750 | 0.0% | 0.04% | -18.6% |
Q2 2018 | $18,000 | +63.6% | 750 | 0.0% | 0.04% | +48.3% |
Q1 2018 | $11,000 | -8.3% | 750 | 0.0% | 0.03% | +3.6% |
Q4 2017 | $12,000 | +71.4% | 750 | +50.0% | 0.03% | +133.3% |
Q3 2017 | $7,000 | 0.0% | 500 | -33.3% | 0.01% | +9.1% |
Q2 2017 | $7,000 | – | 750 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |